The findings support the fact that further extension of nationwide cardiovascular disease (CVD) risk identification programs and prevention strategies to reduce the occurrence of cardiovascular diseases are warranted
Confirmed positive phase 3 topline results in addition to Enavogliflozin monotherapy and Metformin combination therapy
This advanced technology for Diabetic Foot Ulcer (DFU), management has a high scope of preventing amputations in diabetic patients. It has no definitive treatment in India. This technology will be available at affordable rates
The aim is to create an awareness programme that will drive diabetic patients to get their eyes tested regularly
A total of 12 generic medicines have been included in the list
Remote screening of diabetic retinopathy can help in early detection, even before there are any noticeable vision changes
The Phase III programme, Enith1 and Enith2, is expected to launch this quarter
Treatment typically requires frequent injections directly into the eye—an ongoing burden for patients and health systems alike
The clearance marks a major step in Diabeloop’s ambition to become a central partner for insulin pump manufacturers and expand access to automated insulin delivery in the US market
DME is among the most challenging retinal diseases to treat and has long served as a proving ground for therapies that ultimately become first-line standard of care in retinal diseases
Subscribe To Our Newsletter & Stay Updated
